Path G 15mg/2mg Capsule
By Path G
Rx
10 Capsule in a Strip

Composition
Pioglitazone(15mg) + Glimepiride(2mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
January, 2027

liver
When using Path G 15mg/2mg Capsule, it is important to be cautious if you have liver disease. Patients with liver issues may require adjustments to the dose of Path G 15mg/2mg Capsule, so consulting your doctor before starting the medication is crucial. It is not advisable to use Path G 15mg/2mg Capsule in cases of severe liver disease, as these patients may encounter significantly low blood sugar levels, which could improve over an extended period. It is recommended to seek medical guidance and closely monitor liver function while taking Path G 15mg/2mg Capsule if you have liver concerns.

kidney
Path G 15mg/2mg Capsule should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Consulting your doctor is important. Patients with severe kidney disease should not use Path G 15mg/2mg Capsule, as they may experience very low blood sugar levels that can normalize over time.

alcohol
It is not safe to drink alcohol with Path G 15mg/2mg Capsule. Avoid alcohol consumption while taking this medication.

driving
"Do not drive if experiencing symptoms due to low or high blood sugar while taking Path G 15mg/2mg Capsule."

pregnancy
Path G 15mg/2mg Capsule may be unsafe during pregnancy, with limited human studies and potential harm to the developing baby as seen in animal studies. Your doctor will assess the risks and benefits before prescribing. Consult your doctor.

breastfeeding
During breastfeeding, using Path G 15mg/2mg Capsule is likely safe. Studies show it poses minimal risk to the baby. Monitor the baby's blood glucose if the mother is taking Path G 15mg/2mg Capsule.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹94.5
₹105
10% OFF
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025
